TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.

MacLean S Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.